The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

aTyr Pharma Inc

Nasdaq: LIFE
Last

(U.S.) $4.29

Today's change-0.33 -7.14%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.
 

aTyr Pharma Inc

Nasdaq: LIFE
Last

(U.S.) $4.29

Today's change-0.33 -7.14%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

aTyr Pharma Inc down (U.S.)$0.33

aTyr Pharma Inc closed sharply lower Friday, dropping (U.S.)$0.33 or 7.14% to (U.S.)$4.29. Over the last five days, shares have lost 18.75% and are down 56.36% for the last year to date. This security has underperformed the S&P 500 by 82.17% during the last year.

Key company metrics

  • Open(U.S.) $4.56
  • Previous close(U.S.) $4.62
  • High(U.S.) $4.75
  • Low(U.S.) $4.25
  • Bid / Ask-- / --
  • YTD % change-56.36%
  • Volume215,454
  • Average volume (10-day)143,983
  • Average volume (1-month)117,275
  • Average volume (3-month)112,787
  • 52-week range(U.S.) $4.25 to (U.S.) $28.29
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.90
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue----0--
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense111196
Selling / general / administrative4322
Research & development8874
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)------0
Other operating expenses, total--------
Operating income-11-11-9-6
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-11-11-9-6
Income after tax-11-11-9-6
Income tax, total--------
Net income-11-11-9-6
Total adjustments to net income0000
Net income before extra. items-11-11-9-6
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-11-11-9-6
Inc. avail. to common incl. extra. items-11-11-9-6
Diluted net income-11-11-9-6
Dilution adjustment----00
Diluted weighted average shares24152323
Diluted EPS excluding extraordinary itemsvalue per share-0.48-0.74-0.40-0.27
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.48-0.74-0.40-0.28